Business
Half-year Report
MyHealthChecked PLC reported unaudited half-year results, revealing revenue of £0.5 million, down from £0.9 million in H1 2024 and £3.6 million for the full year 2024; however, the wellness portfolio experienced a 60% increase compared to H1 2024. The adjusted EBITDA loss was £1.23 million, slightly higher than the £1.199 million loss in H1 2024, but less than the £1.927 million loss for the full year 2024. Cash balances stood at £5.06 million, a decrease from £6.05 million in H1 2024 but still above the £5.47 million at the end of 2024. Unit sales to end users increasing by 45%, with the most significant growth being in the higher value blood tests where sales volumes increased by 72% versus the same period last year. The company also reported a loss for the period of £1.356 million. Disclaimer*
About this update from Fortis Frontier Plc
[{"type":"text","content":"\n\nMyHealthChecked PLC\n(\"MyHealthChecked\", \"MHC\" the \"Group\" or the \"Company\")\n \nHalf-Year Report\n \nMyHealthChecked PLC, the consumer home-testing healthcare company, announces its unaudited half-year report for the six months ended 30 June 2025.\n \nFinancial highlights\n· Revenue of £0.5m (H1 2024: £0.9m; FY 2024: £3.6m) with wellness portfolio up c60% from H1 2024\n· Adjusted EBITDA loss £1,230,000 (H1 2024: £1,199,000; FY 2024: £1,927,000)\n· Cash balances of £5.06m (H1 2024: £6.05m; FY 2024: £5.47m)\n \nCommercial and operational highlights\n· The Company signed a partnership agreement with Patients Know Best (\"PKB\") to enable customers using at-home blood and DNA tests from MHC to access their laboratory test results via the NHS App\n· MHC became the exclusive supplier of PocDoc into Boots, which was added to the boots.com range in April 2025 and launched in over 830 stores\n· Signed agreement with Boots for the supply of a range of lateral flow self-tests and laboratory tests under the Boots' Own Brand (\"OB\") label\n· End-customer purchases of wellness tests performed well- 45% volume increase year-on-year\n· Phlebotomy kits registered in the UK and EU and will be launched at retail at the earliest opportunity\n \nPenny McCormick, Chief Executive Officer of MyHealthChecked PLC, said:\n\"As a Board we believe in the positive long-term growth potential for our wellness product range, but acknowledge that the category is still in its infancy and that awareness amongst potential end-users is currently limited.\n \n\"As an organisation with deep retail product knowledge, we have built a number of partnerships to support our retail engagement in the home-testing market. In particular, with Boots we are working with a trusted established retail organisation, with both digital reach and a bricks and mortar footprint, and we believe this is key to unlocking revenue potential in the UK market. With several promotional campaigns being launched by Boots in the coming months we expect to see demand increase as the range beds in, and increased product visibility as more shelf space is dedicated to the range in store. This, along with our other com...